On May 21, staff members of NCI’s dissolved Office of Communications and Public Liaison and friends gathered at the house of Peter Garrett and Ken Crerar.
NCI’s Cancer Information Highlights bulletin, a section of NCI’s Weekly Digest Bulletin that informs readers of research updates related to cancer causes, prevention, screening, treatment, and coping, will no longer be published due to restructuring and reductions in force at HHS.
The U.S. House of Representatives voted on the so-called “One Big, Beautiful Bill Act,” this week which included drastic, $715 billion cuts to Medicaid that will result in at least 8.6 million people losing health insurance coverage, including cancer patients and survivors.
FDA Commissioner Marty Makary held a roundtable of independent scientific experts to discuss the safety and necessity of talc as an additive to food, drugs, and cosmetic products.
FDA—under the leadership of cyber-iconoclast and new director of the agency’s Center for Biologics Evaluation and Research, Vinay Prasad—is taking a new approach to COVID-19 vaccines.
In the ongoing escalation of the feud between Harvard University and the Trump White House has imperiled hundreds of research grants at Harvard’s medical school.
Harvard University has sued the Trump administration a second time since the start of the ongoing feud between the university and White House.
A three-judge federal appeals court has lifted a lower court order that blocked the federal government from enacting President Trump’s executive order to end collective bargaining by workers at more than a dozen federal agencies.
Legislation aimed at increasing access to breast and cervical cancer screening was introduced May 22 in the U.S. Senate. The bipartisan Screening for Communities to Receive Early and Equitable Needed Services, or SCREENS, for Cancer Act would reauthorize the National Breast and Cervical Cancer Early Detection Program, or NBCCEDP, for fiscal years 2026 through 2030.
Before two consecutive congressional hearings on the Trump administration’s “skinny budget” proposal on May 14, Sen. Bernie Sanders (I-VT), ranking member of the Senate Health, Education, Labor, and Pensions Committee, released a report assessing the administration’s impact on biomedical research.
